ESPE Patient Information Leaflets - COVID-19

ESPE Physician Information Leaflets - COVID-19

Contributing to developing knowledge on COVID-19


The electronic reporting system e-REC (e-Reporting Of Rare Conditions) is part of the European Registries for Rare Endocrine Conditions (EuRRECa) project, funded by EU CHAFEA and supported by  ENDO-ERN, ESE and ESPE. From April 2020, in close collaboration with the ESE Rare Disease Committee, the system has been extended to include the reporting of COVID-19 infection in patients with an existing endocrine or metabolic bone condition. This is open to all centres that look after people with such conditions.  Learn more and contribute to the e-REC database.

Research related to COVID-19 and paediatric endocrine disorders

Adrenal Insufficiency 

Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary centre

Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study

What we have to know about corticosteroids use during Sars-Cov-2 infection

Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency


General endocrinology

The Impact of SARS-Cov-2 Virus Infection on the Endocrine System

Endocrine and metabolic aspects of the COVID-19 pandemic

Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?

Encountering COVID-19 as Endocrinologists

COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology

Other publications COVID-19 and endocrine disorders

Links to related organisation resources on COVID-19

Paediatric Endocrinology 


Endocrinology and General